GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PainReform Ltd (NAS:PRFX) » Definitions » Price-to-Funds-From-Operations

PRFX (PainReform) Price-to-Funds-From-Operations : (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is PainReform Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


PainReform Business Description

Industry
Traded in Other Exchanges
N/A
Address
65 Yigal Alon Street, Tel Aviv, ISR, 6744316
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.